Skip to Content
Merck
CN

HMI0400

MISSION® microRNA Mimic

hsa-miR-222

Synonym(s):

hsa-miR-222-3p

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12352200
NACRES:
NA.51
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


product line

MISSION®

form

solid

mature sequence

AGCUACAUCUGGCUACUGGGU

Sanger mature/minor accession no.

Sanger microRNA accession no.

storage temp.

−20°C

Gene Information

General description

The ready-to-use MISSION miRNA mimics are small, double-stranded RNA molecules designed to mimic endogenous mature miRNA molecules when introduced into cells. miRNA are known to regulate gene expression in a variety of manners, including translational repression, mRNA cleavage and deadenylation. MISSION miRNA Mimics, a member of MISSION RNAi product family, provides miRNA researchers with a range of options from individual MISSION mimics to a full library of human miRNA mimics based on latest version of miRBase (currently hosted by the University of Manchester, previously hosted by the Sanger Institute).

  • Optimized and ready for transfection.
  • Novel MISSION miRNA mimic design has been functionally tested for knockdown efficiency against natural miRNA targets.
  • Unique MISSION miRNA mimic design significantly reduces possible sense strand off target effects.
  • Available as a whole human library and individual miRNA targets.

Application

MISSION® microRNA Mimic (hsa-miR-222) has been used to study the effect of specific miRNAs on macrophage-derived apoptotic bodies-mediated proliferation of the recipient epithelial cells.

Biochem/physiol Actions

The microRNA hsa-miR-222 (also referred to as hsa-miR-222-3p) targets SOCS3 (suppressor of cytokine signaling 3) and ZFPM2 (zinc finger protein). It is present in the ovarian cancer derived-exosomes and is proposed as a biomarker for diagnosis. Exosomal miR-222-3p is associated with the polarization of tumor-associated macrophages. Also, hsa-miR-222 is downregulated in the plasma of patients with ventricular septal defect.

Other Notes

miRBase V18 Mature ID update: hsa-miR-222-3p

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

常规特殊物品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Characterization of circulating microRNA expression in patients with a ventricular septal defect.
Li D, et al.
PLoS ONE, 9, e106318-e106318 (2014)
Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages.
Ying X
Oncotarget, 7, 43076-43076 (2016)
Ziwen Zhu et al.
Journal of leukocyte biology, 101(6), 1349-1359 (2017-03-10)
Bacterial pneumonia is a common and serious clinical entity. Alveolar epithelial cells and alveolar macrophages are the first line of defense in the innate immunity against bacterial pathogens. Epithelial cells are known to release chemokines/cytokines that recruit and activate phagocytic



Global Trade Item Number

SKUGTIN
HMI0400-5NMOL04061831382426